TAKEDA PHARMACEUTICAL CO LTD NPVTAKEDA PHARMACEUTICAL CO LTD NPVTAKEDA PHARMACEUTICAL CO LTD NPV

TAKEDA PHARMACEUTICAL CO LTD NPV

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪38.67 B‬EUR
‪882.16 M‬EUR
‪26.11 B‬EUR
‪1.51 B‬
Beta (1Y)
0.73

About TAKEDA PHARMACEUTICAL CO LTD

CEO
Christophe Weber
Headquarters
Osaka
Founded
1781
ISIN
JP3463000004
FIGI
BBG00K9Q6877
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0RN3 is 35.2005 EUR — it has decreased by 0.16% in the past 24 hours. Watch TAKEDA PHARMACEUTICAL CO LTD NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange TAKEDA PHARMACEUTICAL CO LTD NPV stocks are traded under the ticker 0RN3.
We've gathered analysts' opinions on TAKEDA PHARMACEUTICAL CO LTD NPV future price: according to them, 0RN3 price has a max estimate of 33.23 EUR and a min estimate of 24.92 EUR. Watch 0RN3 chart and read a more detailed TAKEDA PHARMACEUTICAL CO LTD NPV stock forecast: see what analysts think of TAKEDA PHARMACEUTICAL CO LTD NPV and suggest that you do with its stocks.
0RN3 reached its all-time high on Mar 13, 2018 with the price of 50.6754 EUR, and its all-time low was 2.5398 EUR and was reached on Jan 21, 2019. View more price dynamics on 0RN3 chart.
See other stocks reaching their highest and lowest prices.
0RN3 stock is 0.16% volatile and has beta coefficient of 0.73. Track TAKEDA PHARMACEUTICAL CO LTD NPV stock price on the chart and check out the list of the most volatile stocks — is TAKEDA PHARMACEUTICAL CO LTD NPV there?
Today TAKEDA PHARMACEUTICAL CO LTD NPV has the market capitalization of ‪38.57 B‬, it has increased by 1.93% over the last week.
Yes, you can track TAKEDA PHARMACEUTICAL CO LTD NPV financials in yearly and quarterly reports right on TradingView.
TAKEDA PHARMACEUTICAL CO LTD NPV is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
0RN3 earnings for the last quarter are −0.01 EUR per share, whereas the estimation was 0.01 EUR resulting in a −290.04% surprise. The estimated earnings for the next quarter are 0.19 EUR per share. See more details about TAKEDA PHARMACEUTICAL CO LTD NPV earnings.
TAKEDA PHARMACEUTICAL CO LTD NPV revenue for the last quarter amounts to ‪6.43 B‬ EUR, despite the estimated figure of ‪5.55 B‬ EUR. In the next quarter, revenue is expected to reach ‪6.36 B‬ EUR.
0RN3 net income for the last quarter is ‪−18.48 M‬ EUR, while the quarter before that showed ‪678.82 M‬ EUR of net income which accounts for −102.72% change. Track more TAKEDA PHARMACEUTICAL CO LTD NPV financial stats to get the full picture.
TAKEDA PHARMACEUTICAL CO LTD NPV dividend yield was 4.49% in 2023, and payout ratio reached 204.15%. The year before the numbers were 4.14% and 88.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TAKEDA PHARMACEUTICAL CO LTD NPV EBITDA is ‪7.03 B‬ EUR, and current EBITDA margin is 26.48%. See more stats in TAKEDA PHARMACEUTICAL CO LTD NPV financial statements.
Like other stocks, 0RN3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TAKEDA PHARMACEUTICAL CO LTD NPV stock right from TradingView charts — choose your broker and connect to your account.